P/E ratio for Fulgent Genetics (FLGT)
P/E ratio as of April 2024 (TTM): -12.6
According to Fulgent Genetics 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -12.5854. At the end of 2022 the company had a P/E ratio of 6.30.
P/E ratio history for Fulgent Genetics from 2016 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | 6.30 | 8.34% |
| 2021 | 5.81 | -2.74% |
| 2020 | 5.97 | -100.46% |
| 2019 | < -1000 | 10073.5% |
| 2018 | -12.7 | -56.17% |
| 2017 | -28.9 | 31.24% |
| 2016 | -22.0 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 PAVmed
PAVM | -2.23 | -82.31% | 🇺🇸 USA |
 Philips PHG | -29.5 | 134.03% | 🇳🇱 Netherlands |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.